C ardiovascular disease, including coronary heart disease, is the leading cause of death worldwide (1, 2) . Chest pain with clinical suspicion of coronary artery disease is among the most frequent reasons for urgent care and leads to several million emergency department visits and hospitalizations yearly (3) . Clinical evaluation is often supplemented with noninvasive cardiac imaging despite the lack of evidence for outcome benefits and a low diagnostic yield (4) . The choice of imaging modality is a focus area for comparative effectiveness research (5) .
Coronary computed tomography angiography (CCTA), a relatively new diagnostic modality, has become a dominant means for evaluating patients with chest pain and has impressive diagnostic (6 -8) and prognostic (9 -11) power. Registry data suggest that CCTA can be used to appropriately select patients for cardiac catheterization and coronary revascularization (12, 13) . Randomized trials conducted in low-risk patients with chest pain seen in the emergency department demonstrate that CCTA is more time-efficient and less expensive than standard triage protocols, which usually involve stress testing with electrocardiography (ECG), echocardiography, or radionuclide scintigraphy (14 -17) .
Concerns about CCTA remain, including falsepositive results leading to invasive management (6, 8) , high radiation dose (17, 18) , increased downstream resource utilization (17, 19, 20) , and the relatively low-risk profile and short follow-up of most published prospective studies (14 -17) . Women and ethnic minorities are underrepresented in the existing literature (21) (22) (23) . It is widely appreciated that results of studies performed in men and in homogeneous ethnic populations require validation before widespread clinical application. 
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We studied CCTA in an ethnically diverse, innercity, female-predominant sample of intermediate-risk patients with chest pain admitted to telemetry with planned intermediate follow-up. As a comparison, we used radionuclide stress myocardial perfusion imaging (MPI), our institution's default imaging modality and perhaps the best-studied noninvasive examination for detecting severe coronary heart disease (24) . We hypothesized that, compared with MPI, CCTA would provide superior selection of patients for invasive management and decrease length of stay without compromising patient safety.
METHODS
Design Overview
PROSPECT (Prospective Randomized Outcome trial comparing radionuclide Stress myocardial Perfusion imaging and ECG-gated CCTA) was a randomized, controlled comparative effectiveness trial of initial CCTA versus MPI in patients with chest pain admitted to telemetry at a single center. Enrolled patients clinically required noninvasive imaging to determine management and met predefined intermediate-risk criteria. They were clinically assigned to any physician of a group of approximately 30 managing physicians, most of whom were hospitalists on the physician assistant telemetry service. Assessors of the primary outcome were blinded to trial group; patients, imagers, coronary angiographers, and managing clinicians were not blinded. The complete trial design and rationale have been previously described (25) . The study was approved by our institutional review board, complied with the Health Insurance Portability and Accountability Act, was overseen by an independent data and safety monitoring board, and is registered at ClinicalTrials.gov (NCT00705458).
Setting and Participants
Patients were identified by screening telemetry admissions for chest pain from July 2008 through March 2012 (when the recruitment goal was reached) at our inner-city academic medical center. Patients without known coronary artery disease, as determined by patient and physician interview and review of medical records, were potentially eligible if ECG or serum cardiac biomarkers showed no acute myocardial infarction or ischemia. At least 1 intermediate-risk criterion for death or myocardial infarction in the short term, derived from a guideline for unstable angina management (26), was required: 1) pain for more than 20 minutes, 2) pain onset at exertion within the previous 2 weeks, 3) age older than 70 years, 4) subthreshold elevation of serum troponin T, or 5) nonspecific ST-segment or T-wave changes on ECG at presentation. Exclusion criteria included CCTA, MPI, or cardiac catheterization within the preceding 6 months and contraindications to CCTA, including renal insufficiency, active asthma, poor venous access, allergy to intravenous contrast material or other serious allergy, and dysrhythmia that precluded cardiac gating. All patients provided written, informed consent (forms written in English and Spanish were provided). No patients were excluded as a result of language because a telephone interpretation service was used. Patients were not compensated for participation.
Randomization and Interventions
Blocked, 1:1 randomization was performed by an experienced biostatistician using codes generated by SAS software (SAS Institute). Codes were concealed in sequentially numbered, sealed, opaque envelopes. Trial coordination staff enrolled participants and assigned the initial imaging intervention, which was then formally ordered by the managing hospitalist. Imaging was performed immediately. Scans were interpreted with complete access to clinical information and without blinding. After imaging, the managing physicians made all clinical care decisions without restriction.
The CCTA examinations were performed on conventional 64 -detector-row scanners, with heart rate control by intravenously administered metoprolol tartrate when needed. Coronary calcium was scored. Postcontrast CT angiography was retrospectively gated with ECG-triggered current modulation or was prospectively gated, depending on availability and heart rate. Patients received intravenously administered iodixanol-320, followed by a saline chaser at 5 mL/s. The cardiothoracic radiologist tailored scanner voltage and current, the protocol for injection of contrast material, and premedication with sublingual nitroglycerin. One of several experienced, subspecialty fellowshiptrained cardiothoracic radiologists interpreted the findings by using multiplanar, curved planar, and maximum-intensity projection reconstructions.
EDITORS' NOTES Context
Both coronary computed tomography angiography (CCTA) and radionuclide stress myocardial perfusion imaging (MPI) are used to assess patients with acute chest pain.
Contribution
In patients with acute chest pain admitted to telemetrymonitored wards of an inner-city medical center and randomly assigned to CCTA versus MPI for initial imaging, the percentages of patients with cardiac catheterization and no subsequent revascularization by 1 year were similar. The amount of radiation exposure was lower and measures of patient satisfaction were higher with CCTA.
Caution
The study was conducted at a single site. Clinical management other than imaging was not stipulated.
Radionuclide stress MPI was generally performed by using 1-day dual-isotope (201-Tl rest/99m-Tcsestamibi stress) or 99m-Tc-sestamibi rest/stress imaging. The default stressor was treadmill exercise per the Bruce protocol. Patients unable to exercise received intravenously administered adenosine or regadenoson with or without low-level exercise. The nuclear cardiologist tailored the exact administered dose, radiotracers, and mode of stress. Single photon-emission CT, with gated and attenuation-corrected images, was performed. One of several experienced, certified nuclear cardiologists or nuclear medicine physicians interpreted the findings by using standard quantification algorithms.
Outcomes and Follow-up
The primary outcome was catheterization not leading to percutaneous or surgical revascularization within 1 year. The primary goal of noninvasive coronary imaging is to select patients who may benefit from revascularization and to obviate cardiac catheterization in the remaining patients. Although debate rages regarding the appropriate use of coronary revascularization, catheterization that does not lead to intervention confers limited incremental value and entails risk. This outcome was measured up to 1 year because noninvasive imaging should inform the decision to perform catheterization for a substantial period, and there may be patientrelated reasons for delay of revascularization. Because the decision to revascularize is multifactorial, a subgroup analysis was performed for patients with significantly abnormal findings on initial noninvasive imaging (at least one ≥70% stenotic lesion or ≥50% left main stenosis on CCTA; global interpretation of ischemia or probable ischemia on MPI). More detailed description of imaging results is deferred because our primary outcomes were clinical rather than imaging findings.
Length of hospital stay was calculated from randomization to discharge for all patients. Safety outcomes included complications from imaging and revascularization, posttest renal dysfunction, all-cause mortality, and nonfatal major adverse cardiovascular events (myocardial infarction, cardiac arrest, and cerebrovascular accident). Subsequent resource utilization (hospitalization, emergency department visit, cardiac and noncardiac imaging, and changes in pharmacotherapy) was recorded. Patients' subjective experiences of imaging were assessed on a 10-point Likert-type scale (with 1 indicating the best experience), by comparison with other diagnostic testing on an ordinal scale, by willingness to undergo the procedure again on an ordinal scale, and by recording symptoms immediately after imaging. The persistence of chest pain was assessed at telephone follow-up. Radiation from CCTA was estimated by using the dose-length product and a conversion factor of 0.017 mcSv/mGy × cm. Radiation from MPI was estimated by using recorded standard doses of isotopes and a publically available calculator (27) . Doses from subsequent imaging and catheterization were determined with a publically available calculator (28).
Outcomes were assessed by review of electronic medical records (spanning numerous health system sites) and telephone questionnaires at 6 and 12 months after discharge and at study completion (December 2013). Patients unreachable by telephone and without institutional electronic records were followed up by contacting providers' offices. When patients, physicians, or records indicated that cardiac care was rendered outside our health system, records were requested for review.
Statistical Analysis
The study had 84% power to detect a reduction in catheterization not leading to revascularization from 11% to 3%, with a sample size of 200 per group at an ␣ value of 0.05 (25) . All randomly assigned patients were included in the analysis in the trial group to which they were assigned. The primary outcome was assessed by a Cox proportional hazards model (PROC PHREG in SAS software, version 9.2) with the proportional hazards assumption tested by log-rank and inspection of survival curves. A post hoc exploratory analysis for the primary outcome was performed in patients with severely abnormal results on noninvasive testing. Safety outcome and resource utilization analyses included all patients during the complete follow-up. Proportions were compared by using Fisher exact tests (29) , and 95% CIs were computed for differences (30). The Mann-Whitney U test for independent samples was performed for nonparametric data by using SPSS software, version 20 (IBM). All tests were 2-tailed and performed at an ␣ value of 0.05.
Role of the Funding Source
The American Heart Association Clinical Research Program funded the conduct of the study. The National Center for Advancing Translational Sciences, a component of the National Institutes of Health, funded part of the data analysis. The funding sources had no role in the design, conduct, or reporting of the study or in the decision to publish the manuscript.
RESULTS
Study Patients
Of 400 patients, 200 were randomly assigned to each group (Figure) . The mean age was 57 years; 251 (63%) participants were women and 379 (95%) were ethnic minorities ( Table 1) . Similar proportions of patients completed CCTA (94%) and MPI (95%). Follow-up of at least 1 year for the primary outcome and adverse events was complete in 381 patients (95%). The 19 patients lost to follow-up had similar demographic characteristics (mean age, 56 years; 9 women).
Outcomes
Thirty patients (15%) in the CCTA group and 32 patients (16%) in the MPI group underwent 1 or more cardiac catheterizations within 1 year (P = 0.89) ( Table  2) . Of these, 15 in the CCTA group and 20 in the MPI group did not have revascularization (unadjusted haz-ORIGINAL RESEARCH CCTA Versus Nuclear Stress for Chest Pain ard ratio, 0.77 [95% CI, 0.40 to 1.49]; P = 0.44). The median times to catheterization and revascularization were 3.5 days (interquartile range [IQR], 2 to 28.5) and 2 days (IQR, 1.5 to 3.5), respectively, for CCTA and 2 days (IQR, 1 to 5) and 1.5 days (IQR, 1 to 4), respectively, for MPI. In the exploratory subgroup of patients with significantly abnormal findings on CCTA or MPI, 5 of 20 (25%) and 16 of 31 (52%) had catheterization that did not lead to revascularization, respectively (absolute difference, Ϫ27 percentage points [CI, Ϫ50 to 3.9 percentage points]; P = 0.083). The median lengths of stay in the CCTA and MPI groups were 28.9 hours (IQR, 11.0 to 48.4) and 30.4 hours (IQR, 23.9 to 51.3), respectively (P = 0.057). No patients in either group had posttest renal dysfunction. The median follow-up for safety outcomes was 41.7 months (IQR, 28.6 to 51.0) and 39.0 months (IQR, 28.3 to 51.6) for CCTA and MPI, respectively. One patient in the CCTA group and 6 in the MPI group died during follow-up (P = 0.122) at a median of 24.5 months after recruitment. Nine patients in the CCTA group and 9 in the MPI group had nonfatal major adverse cardiovascular events.
Clinical and imaging resource utilization is shown in Table 3 .
Three CCTA recipients had noncoronary diagnoses that led to surgery (1 ascending aortic aneurysm, 1 
Follow-up
CCTA was not performed in 13 patients because of patient refusal (n = 9), physician decision (n = 1), technical difficulty (n = 1), and safety concerns (n = 2); of these, 7 patients received MPI. MPI was not performed in 11 patients because of patient refusal (n = 6), physician decision (n = 4), and technical difficulty (n = 1); of these, 0 patients received CCTA. During hospitalization, 6 patients who received initial CCTA had additional MPI and 4 patients who received initial MPI had additional CCTA. Patients lost to follow-up could not be contacted by any means, including identification and inquiry of any treating physicians. All patients were included in the primary analysis (Cox proportional hazards model). CAD = coronary artery disease; CCTA = coronary computed tomography angiography; ICD = implantable cardioverter-defibrillator; MPI = radionuclide stress myocardial perfusion imaging. * Based on admission to telemetry from the emergency department for chest pain and absence of acute myocardial infarction or ischemia. † Recent imaging means CCTA, MPI, or cardiac catheterization within 6 mo. ‡ Managing physician had already chosen a noninvasive imaging modality and would not allow the patient to be randomly assigned. § Other reasons for exclusion are listed in the Appendix Table ( atrial septal defect, and 1 adrenal pheochromocytoma). Seven CCTA recipients had extracardiac diagnoses that explained their symptoms (4 cases of acute pulmonary emboli and 3 cases of pneumonia). No MPI recipients had noncoronary surgical diagnoses or extracardiac explanations of symptoms.
Radiation Doses
The CCTA and MPI dose was available for 184 of 187 (98%) and 189 of 189 (100%) patients who received their randomly assigned examination, respectively ( Table 4 ). The median effective dose was significantly lower for CCTA (9.6 mSv [IQR, 6.2 to 23]) than for MPI (27 mSv [IQR, 19 to 27]) (P < 0.001). Marked dose reduction trends were noted in both groups during the study period. Through the end of follow-up, both CCTA and MPI recipients underwent a median of 3 (IQR, 1 to 9) noncardiac studies involving radiation. The estimated median radiation doses were 2 mSv (IQR, 0.003 to 16) for CCTA and 2 mSv (IQR, 0.004 to 17) for MPI.
Subjective Patient Experience
We assessed subjective patient experience of the imaging examination in all patients who underwent their randomly assigned study. Complete data were available for 186 of 187 patients in the CCTA group and 188 of 189 patients in the MPI group. The median examination rating scores (out of 10; 1 being highest) were 2 (IQR, 1 to 3) and 2 (IQR, 1 to 3.5) for CCTA and MPI, respectively (P = 0.149). Twenty-eight (14%) CCTA and 45 (23%) MPI recipients rated their test less positively, with an ordinal score of 5 (descriptor of 
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"OK") or worse (P = 0.038). Recipients of CCTA graded their study more favorably than did MPI recipients in comparison with other diagnostic tests they had previously had (P = 0.001) and in willingness to have the examination again (P = 0.003). Forty-five of 186 (24%) CCTA recipients and 46 of 188 (24%) MPI recipients reported 1 or more general adverse reactions, most commonly headache, nausea, dizziness, and feeling of warmth. One CCTA recipient and 30 MPI recipients reported chest pain, shortness of breath, or palpitations (P < 0.001). Three CCTA recipients and no MPI recipients reported rash or pruritus (P = 0.25).
One hundred seventy-seven patients in the CCTA group and 180 in the MPI group provided information about symptoms at 6-or 12-month telephone interviews. Sixty-four (36%) patients in each group had continued chest pain, which was the same or worse in 28 CCTA recipients and 23 MPI recipients.
DISCUSSION
To our knowledge, this single-center, randomized, controlled comparative effectiveness trial is the first to directly compare CCTA and MPI in acutely symptomatic, intermediate-risk patients with chest pain with intermediate-term follow-up (median, 40 months). The present study sample-predominately women (63%) and ethnic minorities (95%) of low socioeconomic status and with a high incidence of obesity (mean body mass index, 31 kg/m 2 )-is understudied and differs from patients in previous randomized trials (14 -17) . Some Table 2 and the text, which report catheterizations within 1 y.
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studies have compared standard care with early CCTA (14, 17) ; the present study gave parity to both examinations, which were performed at the same place in the treatment algorithm. This study included only patients who clinically required noninvasive imaging; in contrast, many standard-care patients in the largest emergency department CCTA trials received no imaging (16, 17) . We found no significant difference between CCTA and MPI in the primary outcome, cardiac catheterizations not leading to revascularization. The moderate study sample size does limit the ability to detect a small difference between imaging modalities, but the clinical importance of such a difference is uncertain. These data mirror those from a large retrospective study showing that most nonemergent cardiac catheterizations demonstrate no clinically significant disease (31) and suggest that this holds true even for patients prescreened with currently leading noninvasive imaging. In our exploratory subgroup analysis of patients with significantly abnormal results on initial imaging, there were fewer catheterizations not leading to revascularization in the CCTA group; this difference did not reach statistical significance (25% versus 52%; P = 0.083). The recently published PROMISE (PROspective Multicenter Imaging Study for Evaluation of chest pain) trial of 10 000 symptomatic outpatients demonstrated that CCTA results in a statistically significant, 0.9% reduction in catheterizations showing no obstructive coronary disease compared with various forms of functional testing (32) . The decision to catheterize patients remains dependent on factors other than initial noninvasive imaging, such as clinical presentation, persistence of symptoms, repeated clinical encounters, subsequent testing, and clinician and patient preference. These data suggest a small potential benefit of initial CCTA.
We found no difference between CCTA and MPI in cardiac catheterizations within 1 year (15% versus 16%). This differs with research derived from a retrospective review of Medicare claims data (19) , a meta-analysis of randomized trials in low-risk emergency department patients (20) and a large multicenter trial of outpatients (32) , all of which showed increased catheterizations after CCTA. We observed that the time to catheterization was longer for CCTA than MPI, which probably reflects the desire to avoid potentially nephrotoxic, immediate consecutive administrations of intravenous contrast material. We found no significant difference between CCTA and MPI in percutaneous coronary interventions (4% versus 5.5%), a finding that also differs from those of the prior studies. Although the reasons for these differences are uncertain, the diverse patient settings (inpatient, emergency department, outpatient) could play a role.
We found an increase in coronary artery bypass surgery in the CCTA group versus the MPI group (4% versus 0.5%; P = 0.068), which is confirmed by a large trial in outpatients showing near doubling of the rate for patients undergoing CCTA (32) . This could be explained by "balanced" ischemia, which is a known limitation of MPI. Alternatively, the increase in coronary bypass in the CCTA group could be due to overtreatment because both CCTA and catheterization demonstrate anatomical stenosis and are more similar to each other than to MPI, a physiologic modality. However, if this were the case, we would have expected more percutaneous interventions in the CCTA group, which we did not observe. Major adverse cardiovascular events were similar between the 2 groups; similar event rates are also reported in outpatients undergoing CCTA and functional testing (32) . We found that CCTA indicated clinically important noncoronary diagnoses in 10 patients (5%), some of which led to surgery. These would not reasonably have been diagnosed by MPI and represent an advantage of CCTA.
Length of stay did not meaningfully differ between the CCTA and MPI groups (median, 29 versus 30 hours), whereas prior published trials in emergency department patients favored CCTA (14 -17) . A likely reason for this difference is that patients in the current study were recruited without immediate availability of dedicated CCTA scanners. In addition, our higher-risk patients (with intermediate-level criteria for predicting death or myocardial infarction in the short term) had a higher incidence of catheterization and revascularization. These interventions were usually performed during the same hospitalization. The speed of an imaging study highly depends on local facilities and practice patterns. This limits the generalizability of analysis of length of stay.
Downstream resource utilization, including repeat hospitalizations and emergency department visits for cardiac and noncardiac symptoms, outpatient cardiologist and primary care visits, noninvasive cardiac imaging, and catheterization, did not differ between the CCTA and MPI groups. This is at variance with retrospectively analyzed Medicare claims data (19) . New as- ORIGINAL RESEARCH CCTA Versus Nuclear Stress for Chest Pain pirin and statin therapy did not differ significantly between the CCTA and MPI groups. Radiation doses for initial imaging were significantly lower for CCTA than MPI (median, 9.6 versus 27 mSv), which decreased but remained highly significant during long-term follow-up when both cardiac and overall imaging were considered (median, 24 versus 27 mSv). For comparison purposes, according to an accepted linear extrapolation (28), 10 mSv confers a lifetime risk for fatal cancer induction of 50 per 100 000 in 60-year-old patients. The large reported doses in this study directly reflect the higher-radiation thallium isotope used for imaging most of our patients receiving MPI. Recent trends favor lower-dose, sestamibi-only protocols, which have been formally adopted at our institution (as of February 2011) and elsewhere. Additional recent advances in radiation dose reduction have been achieved with high-efficiency MPI (33) and newer CCTA scanner technology (34).
Patients rated their noninvasive imaging experience with CCTA better than did those in the MPI group (fewer unfavorable experience ratings), in comparison with other diagnostic tests and greater willingness to undergo the examination again. This correlates with the higher incidence of patient reports of chest pain, palpitations, and shortness of breath with MPI. Persistent chest pain did not significantly differ between the CCTA and MPI groups; about one third of patients remained symptomatic in each group.
This study has several limitations. Foremost, this was a single-center study, and institution-specific factors may limit generalizability. However, our majorityfemale, ethnically diverse, low-income population remains understudied. Our sample size is similar to that of most previous CCTA studies, and the follow-up is far longer. The current study included only patients who were appropriate candidates for both CCTA and MPI; it did not assess other types of imaging.
Second, the decisions to perform cardiac catheterization and revascularization, the components of our primary outcome, were made clinically without a predefined algorithm. The managing physicians were clinically assigned and not blinded. Factors other than initial imaging played a role in treatment decisions, closely resembling real-life practice, which is also not constrained by strict algorithms for management.
Third, the identification of clinical events and subsequent resource utilization, including follow-up of incidental findings on CCTA, is limited to our health system network and follow-up discussions with patients and their physicians. Downstream events at other institutions could be missed because there is no unified system for medical records. This study is underpowered to detect potentially important differences in clinical events and resource utilization.
Fourth, major advancements in CCTA (such as CCTA fractional flow reserve [35] and perfusion [36] ) and nuclear cardiology (such as positron emission tomography techniques [37] , including coronary flow reserve [38] ) are continuous and significantly alter the performance characteristics of these types of imaging over time.
Fifth, data on radiation dose are based on imaging protocols that have changed over the time of the study and rely on standardized recorded amounts of isotopes. Finally, the CCTA group included more patients older than 70 years (17% versus 10%), a potential source of bias.
In conclusion, the present study demonstrated no significant difference between initial CCTA and MPI in catheterization not leading to revascularization, a measure of performance in selecting patients for invasive management. A trend toward more coronary bypass grafting in the CCTA group remains of uncertain clinical impact. Length of stay, downstream resource utilization, and clinical events also did not differ between the CCTA and MPI groups in this diverse, inner-city population at intermediate-term follow-up, and CCTA was associated with lower radiation dose and a better patient experience.
From Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York.
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